echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 781 drugs withdrew from the procurement platform: either production was suspended or costs increased...

    781 drugs withdrew from the procurement platform: either production was suspended or costs increased...

    • Last Update: 2021-09-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    781 drugs withdrew from the procurement platform, involving multiple varieties such as pediatric paracetamol Huangnamin granules, emergency branch syrup, and cefadroxil tablets


    781 drugs withdrawn from the procurement platform

    781 drugs withdrawn from the procurement platform

    A few days ago, the Heilongjiang Provincial Medical Insurance Bureau issued the "Notice on the withdrawal of some drugs from the provincial procurement platform" (hereinafter referred to as the "Notice"), involving 781 drugs and 167 companies


    According to the "Notice", a total of 781 drugs have been withdrawn from the procurement platform of Heilongjiang Province this time, including many commonly used drugs such as Pediatric Paracetamol Huangnamin Granules, Ganmaokang Capsules, Xinkeshu Capsules, Jizhi Syrup, and Cefadroxil Tablets


    As for the reasons for withdrawing from the provincial procurement platform, it mainly involves many aspects, including rising costs and inability to supply at current prices; suspension of production; adjustment of production lines; price inversion; raw material problems and inability to produce.


    Price is the main reason for withdrawal

    Price is the main reason for withdrawal

    Among the 781 drugs that were withdrawn from the network this time, "increased production costs, unable to be supplied at current prices" and "stop production" were the main reasons for the withdrawal.


    For example, the reference price of Xinkeshu Capsules produced by Chongqing Xier'an Pharmaceutical Co.


    The net reference price of nifedipine tablets produced by Guangdong Huanan Pharmaceutical Group Co.


    Guangzhou Baiyunshan Zhongyi Pharmaceutical Co.


    In addition, there is also a price-related exit reason-because the company can lower the price as required, the non-selected drug price linkage declaration in Heilongjiang Province did not declare it


    For example, prucalopride succinate, a subsidiary of Johnson & Johnson subsidiary Xi'an Janssen, has a reference price of 12.


    Escitalopram oxalate tablets produced by Danish Lundbeck Pharmaceuticals and subpackaged by Xi'an Janssen Pharmaceuticals also withdrew because they did not reduce their prices as required


    A large number of drugs are discontinued

    A large number of drugs are discontinued

    "Suspension of production" is the second largest reason for withdrawal of the network after "cost increase".


    For example, Renhetang Pharmaceutical Co.


    In addition, the Naozhenning granules of Shanxi Zhendong Ante Biopharmaceutical Co.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.